Wyeth/Progenics Oral Methylnaltrexone Pushed Back A Year To Test New Formula
This article was originally published in The Pink Sheet Daily
Executive Summary
Companies expect to submit an NDA for the oral formulation to treat opioid-induced constipation in 2009/2010 after initiating a new Phase II trial.